Simplex Trading
NYMX

Simplex Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Simplex Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,113
Closed -$403 – 10887
2022
Q3 		$0 Sell
1,113
-3,990
-78% -$1.59K ﹤0.01% 11258
2022
Q2 		$2K Sell
5,103
-4,523
-47% -$4.16K ﹤0.01% 9480
2022
Q1 		$12K Sell
9,626
-6,760
-41% -$10.4K ﹤0.01% 8766
2021
Q4 		$21K Buy
16,386
+9,008
+122% +$14.4K ﹤0.01% 8334
2021
Q3 		$11K Hold
7,378
– – ﹤0.01% 8898
2021
Q2 		$11K Buy
7,378
+1,885
+34% +$3.49K ﹤0.01% 9068
2021
Q1 		$12K Buy
5,493
+4,531
+471% +$11.9K ﹤0.01% 7820
2020
Q4 		$2K Sell
962
-2,636
-73% -$5.82K ﹤0.01% 8043
2020
Q3 		$8K Sell
3,598
-499
-12% -$1.45K ﹤0.01% 6927
2020
Q2 		$14K Sell
4,097
-4,185
-51% -$13.2K ﹤0.01% 6468
2020
Q1 		$19K Buy
+8,282
New +$23.2K ﹤0.01% 6016
2018
Q4 		– Sell
-120,273
Closed -$220K – 8061
2018
Q3 		$295K Buy
120,273
+53,393
+80% +$158K ﹤0.01% 3203
2018
Q2 		$224K Buy
66,880
+57,227
+593% +$220K ﹤0.01% 3354
2018
Q1 		$40K Sell
9,653
-41,151
-81% -$143K ﹤0.01% 2670
2017
Q4 		$167K Buy
50,804
+45,863
+928% +$167K 0.01% 1408
2017
Q3 		$18K Sell
4,941
-3,720
-43% -$14.1K ﹤0.01% 3266
2017
Q2 		$38K Sell
8,661
-38,062
-81% -$156K ﹤0.01% 2654
2017
Q1 		$169K Buy
46,723
+41,861
+861% +$138K 0.01% 1347
2016
Q4 		$12K Buy
+4,862
New +$15.1K ﹤0.01% 3591
2016
Q3 		– Sell
-10
Closed -$33 – 6651
2016
Q2 		$0 Sell
10
-5,566
-100% -$13.7K ﹤0.01% 6631
2016
Q1 		$13K Sell
5,576
-753
-12% -$1.78K ﹤0.01% 3243
2015
Q4 		$20K Buy
6,329
+4,829
+322% +$16.2K ﹤0.01% 2703
2015
Q3 		$5K Buy
+1,500
New +$3.49K ﹤0.01% 4025

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
CF
Corrigan Financial Middletown, Rhode Island $485M AUM 4.29% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's NYMX Position: Q4 2022 in Review

Simplex Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2022, closing a stake of 1,113 shares — an estimated $403 sold.

Simplex Trading first reported a position in NYMX in Q3 2015 and held it in 23 quarters. The position peaked at $295K in Q3 2018. 37 funds tracked by Wall St. Rank hold NYMX as of Q4 2022.

  • Simplex Trading reported no remaining Nymox Pharmaceutical Corp position as of Q4 2022 after selling out during the quarter.
  • Simplex Trading sold 1,113 Nymox Pharmaceutical Corp shares in Q4 2022, an estimated $403.
  • Simplex Trading first reported a position in Nymox Pharmaceutical Corp in Q3 2015 and held it in 23 quarters.
  • Simplex Trading's Nymox Pharmaceutical Corp position peaked at $295K in Q3 2018.
  • 37 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.